CO56 Comparative Efficacy of Asciminib vs. Second-Generation TKIs in Newly Diagnosed PhCML Using Unanchored Matching-Adjusted Indirect Comparisons
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.158
https://www.valueinhealthjournal.com/article/S1098-3015(25)02715-9/fulltext
Title :
CO56 Comparative Efficacy of Asciminib vs. Second-Generation TKIs in Newly Diagnosed PhCML Using Unanchored Matching-Adjusted Indirect Comparisons
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02715-9&doi=10.1016/j.jval.2025.09.158
First page :
Section Title :
Open access? :
No
Section Order :
11894